1. The spectrum of thyroid disease in a community;Tunbridge, W.M.G.; Evered, D.C.; Hall, R.; Appleton, D.; Bruwis, M.; Clarke, F.;Clin Endocrinol,1977
2. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration;Allanic, H.; Fauchet, R.; Orgiazzi, J.; Madec, A.M.; Genetet, B.; Lorcy, Y.;J Clin Endocrinol Metab,1990
3. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to TSH receptors and on the risk of recurrence of hyperthyroidism;Hashizume, K.; Ichikawa, K.; Sakurai, A.; Suzuki, S.; Takeda, T.; Kobayashi, M.;N EnglJ Med,1991
4. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States;Wartofsky, L.; Glinoer, D.; Solomon, D.;Thyroid,1991
5. Long-term follow-up of treatment of thyrotoxicosis by three different methods;Franklyn, J.A.; Daykin, J.; Drolc, Z.; Farmer, M.; Sheppard, M.C.;Clin Endocrinol,1991